As a result, tumor cells with different sstrs expression were chosen for virotherapy assay, including U-2 OS which expresses all sstr1-5, B16 that highly expresses sstr1, sstr3 and sstr4, and CT26 expressing high sstr2 and sstr5. This evidence concerns the gene SSTR5 and neoplasm.